Literature DB >> 12588654

Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus.

K A Jørgensen1, P B Koefoed-Nielsen, N Karamperis.   

Abstract

The mode of immunosuppressive action of tacrolimus (FK506) and cyclosporin A has been elucidated. Both drugs bind to proteins in the cytoplasm to form complexes, which in turn inhibit the phosphatase activity of calcineurin, an important limiting step in the activation of T cells. The association between drug uptake (pharmacokinetics) and enzyme inhibition (pharmacodynamics) is under current investigation. Great variations in the correlation between blood drug levels and enzyme inhibition could indicate that monitoring calcineurin phosphatase activity for treatment might be superior to monitoring blood drug levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588654     DOI: 10.1046/j.1365-3083.2003.01221.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

Review 1.  Advances in the current treatment of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

Review 2.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

Review 3.  Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.

Authors:  Jeannine S McCune; Meagan J Bemer
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

Review 4.  Immunosuppressive peptides and their therapeutic applications.

Authors:  Kathrin Thell; Roland Hellinger; Gernot Schabbauer; Christian W Gruber
Journal:  Drug Discov Today       Date:  2013-12-11       Impact factor: 7.851

5.  Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells.

Authors:  Sung-Young Shin; Min-Wook Kim; Kwang-Hyun Cho; Lan K Nguyen
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

Review 6.  Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema.

Authors:  Ryohei Ogino; Tomoharu Yokooji; Maiko Hayashida; Shota Suda; Sho Yamakawa; Kenji Hayashida
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

7.  The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster.

Authors:  Kathryn E Bushley; Rajani Raja; Pankaj Jaiswal; Jason S Cumbie; Mariko Nonogaki; Alexander E Boyd; C Alisha Owensby; Brian J Knaus; Justin Elser; Daniel Miller; Yanming Di; Kerry L McPhail; Joseph W Spatafora
Journal:  PLoS Genet       Date:  2013-06-20       Impact factor: 5.917

8.  Isogarcinol is a new immunosuppressant.

Authors:  Juren Cen; Mingshu Shi; Yanfang Yang; Yanxia Fu; Hailing Zhou; Mengqi Wang; Zhenyi Su; Qun Wei
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

9.  Biliary diseases in heart transplanted patients: a comparison between cyclosporine A versus tacrolimus-based immunosuppression.

Authors:  J Stief; H U Stempfle; M Götzberger; P Uberfuhr; M Köpple; P Lehnert; C Kaiser; Uwe Schiemann
Journal:  Eur J Med Res       Date:  2009-05-14       Impact factor: 2.175

Review 10.  Role of endoplasmic reticulum stress in drug-induced toxicity.

Authors:  Fabienne Foufelle; Bernard Fromenty
Journal:  Pharmacol Res Perspect       Date:  2016-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.